Question 1 · Hard
A pre-employment health program screens 20,000 adults for hepatitis C antibody, with an expected prevalence of 0.5%. The screening immunoassay has a sensitivity of 99.0% and a specificity of 98.0%. Every reactive sample is then tested with a second, independent immunoassay that has a sensitivity of 98.0% and a specificity of 99.5%; assume that the two assays' errors are unrelated. Only samples reactive on both assays are reported as antibody positive. About what proportion of the people reported as antibody positive truly have the antibody?
- AAbout 20%
- BAbout 50%
- CAbout 99.5%
- DAbout 98%
Show answerHide answer
Answer: D · About 98%
Of 20,000 people, 100 have the antibody and 19,900 do not. The screen detects 99 of them (99%) and is falsely reactive in 398 (2% of 19,900), so on its own its PPV is only 99 / 497 ≈ 20%. The second assay is applied to this reactive group, where the prevalence is now about 20%: it confirms 97 true positives (98% of 99) and only 2 false positives (0.5% of 398). The PPV of the two-assay result is therefore 97 / 99 ≈ 98%. This is why, at low prevalence, reactive screening results are confirmed before they are reported.
- A: About 20% is the PPV of the screening assay used alone.
- B: About 50% is what the second assay would give if used alone on all 20,000 people.
- C: 99.5% is the second assay's specificity, not a predictive value.